Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Government Programs

In this episode of the Oliver Wyman Health Podcast, we're live from London to talk UK healthcare's advancements in technology, and cracking brain cancer.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.

Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

We reviewed the approaches State legislators took to offset the effect of defunding CSRs. Here are our observations of activity across the country.

Principal, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting

The future of medicine is bright, as opportunities from companies like Apple may soon overhaul the industry. But is true patient empowerment a realistic expectation?

President, CareJourney
President, Commonwealth Fund

Blockchain’s impact on healthcare interoperability is unknown. But those healthcare leaders who understand blockchain's technical merits will stay relevant tomorrow.

Partner, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

High medical trend rates continue to impact Chinese employees. Learn why Chinese employers should develop sound investment strategies around cost drivers.

Senior Partner and President, Growth Markets Region, Mercer

The Middle East is working to redefine its healthcare system amidst governmental regulation. Here are four key trends for a market on the leading edge of innovation.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Why are premiums rising amidst the Affordable Care Act market? It's not because of medical trends, says Oliver Wyman's 2018 Carrier Trend Survey.

Partner, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman Actuarial Consulting

Here’s more on how proposed modifications to CMS’ Advance Notice Summary may affect reimbursement, payment growth rates, and regulation.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

Here are some greater implications and carrier considerations regarding draft regulation changes for association health plans.

Principal, Oliver Wyman Actuarial Consulting
Partner, Oliver Wyman Actuarial Consulting
Partner, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

Insights in your inbox

Subscribe